Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9526
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRerksuppaphol, Sen
dc.contributor.authorHardikar, Wen
dc.contributor.authorMidolo, P Den
dc.contributor.authorWard, Pen
dc.date.accessioned2015-05-15T22:39:07Z
dc.date.available2015-05-15T22:39:07Z
dc.date.issued2003-07-01en
dc.identifier.citationJournal of Paediatrics and Child Health; 39(5): 332-5en
dc.identifier.govdoc12887661en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9526en
dc.description.abstractTo determine the resistance rate to four antimicrobial agents commonly used in the treatment of Helicobacter pylori infection in children.Between July 1997 and January 2000, all H. pylori isolates from children undergoing gastroscopy were prospectively collected and subcultured to yield the susceptibility to four antimicrobial agents by E-test. In all, 23 isolates were tested. Demographic data, presenting symptoms, treatment regimen and clinical improvement after treatment were collected retrospectively.The resistance rate of H. pylori to metronidazole and clarithromycin were 43.5% and 8.7%, respectively. No H. pylori strains were resistant to amoxycillin or tetracycline. There were no statistically significant differences in age, sex, ethnicity, presenting symptoms or clinical improvement after treatment between antimicrobial-susceptible and antimicrobial-resistant groups.The frequent resistance of H. pylori to metronidazole and moderate resistance to clarithromycin in children are comparable with local adult data. The incidence of resistance tended to be higher in patients of non-European ethnicity, but this was not statistically significant. Given that the primary goal of therapy is eradication, and that local resistance rates are high, recommendations for H. pylori management may need to be modified to include sensitivity testing and/or determination of eradication in all patients.en
dc.language.isoenen
dc.subject.otherAmoxicillin.pharmacology.therapeutic useen
dc.subject.otherAnti-Bacterial Agents.pharmacology.therapeutic useen
dc.subject.otherAustraliaen
dc.subject.otherChilden
dc.subject.otherClarithromycin.pharmacology.therapeutic useen
dc.subject.otherDrug Resistance, Microbialen
dc.subject.otherFemaleen
dc.subject.otherHelicobacter Infections.drug therapyen
dc.subject.otherHelicobacter pylori.drug effects.isolation & purificationen
dc.subject.otherHospitals, Pediatricen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMetronidazole.pharmacology.therapeutic useen
dc.subject.otherTetracycline.pharmacology.therapeutic useen
dc.subject.otherVictoriaen
dc.titleAntimicrobial resistance in Helicobacter pylori isolates from children.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of paediatrics and child healthen
dc.identifier.affiliationDepartment of Paediatric Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Austin Hospital, Melbourne, Victoria, Australiaen
dc.description.pages332-5en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/12887661en
dc.type.austinJournal Articleen
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Feb 10, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.